Stock ADDV B ADDVISE GROUP AB
Add to a list
To use this feature you must be a member
Log inSign up

Ratings ADDvise Group AB Nasdaq Stockholm

Equities

ADDV B

SE0007464862

Market Closed - Nasdaq Stockholm
Other stock markets
 16:29:41 31/05/2024 BST 		5-day change 1st Jan Change
8.15 SEK +2.52% Intraday chart for ADDvise Group AB +11.49% -40.25%
05-21 ADDvise Group AB Receives Order Worth USD 1.4 Million CI
05-03 ADDvise Group AB Announces Board Appointments CI

Summary

  • From a short-term investment perspective, the company presents a deteriorated fundamental situation

Strengths

  • The earnings growth currently anticipated by analysts for the coming years is particularly strong.
  • Before interest, taxes, depreciation and amortization, the company's margins are particularly high.
  • Over the past year, analysts have regularly revised upwards their sales forecast for the company.
  • The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.

Weaknesses

  • The company is in a hindered financial situation with significant debt and rather low EBITDA levels.
  • The sales outlook for the group was lowered in the last twelve months. This change in forecast points out a decline in activity as well as pessimistic analyses of the company.
  • For the past year, analysts have significantly revised downwards their profit estimates.
  • For the last four months, earnings estimated by analysts have been revised downwards with respect to the next two years.
  • The average price target of analysts who are interested in the stock has been significantly revised downwards over the last four months.

Ratings chart - Surperformance

Sector: Medical Equipment, Supplies & Distribution

1st Jan change Capi. Investor Rating ESG Refinitiv
ADDVISE GROUP AB Stock ADDvise Group AB
-40.25% 158M -
ABBOTT LABORATORIES Stock Abbott Laboratories
-7.16% 178B
C+
MEDTRONIC PLC Stock Medtronic plc
-1.23% 107B
C
BECTON, DICKINSON AND COMPANY Stock Becton, Dickinson and Company
-4.86% 67.04B
A
DEXCOM, INC. Stock DexCom, Inc.
-4.28% 47.24B
B-
CENCORA, INC. Stock Cencora, Inc.
+10.32% 44.62B
B-
HOYA CORPORATION Stock Hoya Corporation
+8.14% 42.5B
B+
METTLER-TOLEDO INTERNATIONAL, INC. Stock Mettler-Toledo International, Inc.
+15.76% 29.99B
B
TERUMO CORPORATION Stock Terumo Corporation
+15.53% 25.22B
A-
WEST PHARMACEUTICAL SERVICES, INC. Stock West Pharmaceutical Services, Inc.
-5.88% 24.14B
A-
Investor Rating
Trading Rating
ESG Refinitiv
-

Financials

Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances

Valuation

P/E ratio
EV / Sales
Price to Book
-
Price to Free Cash Flow
Yield
-

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
-
12m Revision of opinion
-

Business Predictability

Analyst Coverage
Divergence of Estimates
-
Divergence of analysts' opinions
-
Divergence of Target Price
-
Earnings quality
  1. Stock Market
  2. Equities
  3. ADDV A Stock
  4. ADDV B Stock
  5. Ratings ADDvise Group AB